🔴 Alzamend Neuro is trading 7% down today with no clear company-specific catalyst found

Alzamend Neuro is trading at $1.22 (-6.87%) in pre-market, extending a downward move from its $1.31 close on July 31 despite a lack of company-specific news.

• No verified company announcements, earnings updates, or major regulatory filings have been released to explain the current price action.
• The decline contrasts with broader market sentiment, as U.S. futures and major indexes are currently pointing higher.
• In the absence of a specific catalyst, the move likely reflects thin pre-market trading volume or sentiment-driven pressure.